» Articles » PMID: 18373419

Theranostic Nanomedicine for Cancer

Overview
Specialty Biotechnology
Date 2008 Apr 1
PMID 18373419
Citations 124
Authors
Affiliations
Soon will be listed here.
Citing Articles

Digital Barcodes for High-Throughput Screening.

Yang Z, Chen J, Xiao Y, Yang C, Zhao C, Chen D Chem Bio Eng. 2025; 1(1):2-12.

PMID: 39973970 PMC: 11835184. DOI: 10.1021/cbe.3c00085.


Advancements in nanotheranostics for glioma therapy.

Sahoo L, Paikray S, Tripathy N, Fernandes D, Dilnawaz F Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39480526 DOI: 10.1007/s00210-024-03559-w.


Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.

Petrovic S, Bita B, Barbinta-Patrascu M Int J Mol Sci. 2024; 25(11).

PMID: 38892030 PMC: 11172476. DOI: 10.3390/ijms25115842.


Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway.

Qin J, Zhang C, Zhao Y, Tan D, Wu P, Shui X Mol Pharm. 2023; 20(12):6226-6236.

PMID: 37955533 PMC: 10699304. DOI: 10.1021/acs.molpharmaceut.3c00621.


Green synthesis, characterization of melatonin-like drug bioconjugated CoS quantum dots and its antiproliferative effect on different cancer cells.

Balpinar O, Nadaroglu H, Hacimuftuoglu A Mol Biol Rep. 2023; 50(11):9143-9151.

PMID: 37768465 DOI: 10.1007/s11033-023-08817-3.